Arka Myo DCI Tablets are specifically formulated to provide targeted support for women’s hormonal health and reproductive function. Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by hormonal imbalances, insulin resistance, and ovarian dysfunction. Myo-inositol and D-chiro inositol, two naturally occurring forms of inositol, have been shown to play key roles in regulating insulin sensitivity, ovarian function, and menstrual cycle regularity, making them valuable supplements for women with PCOS and related conditions.

Myo-inositol is a member of the B vitamin family and serves as a precursor to various signaling molecules involved in cellular metabolism and hormone regulation. It plays a crucial role in insulin signaling and glucose metabolism, helping improve insulin sensitivity and reduce insulin resistance, which are common features of PCOS. By restoring insulin sensitivity, myo-inositol helps lower circulating insulin levels, thereby reducing androgen production, promoting ovulatory function, and restoring menstrual regularity.

D-chiro inositol is another biologically active form of inositol that works synergistically with myo-inositol to regulate insulin signaling and ovarian function. Research suggests that women with PCOS have altered ratios of myo-inositol to D-chiro inositol, leading to impaired ovarian function and hormone imbalances. Supplementation with D-chiro inositol helps restore the balance between these two forms of inositol, promoting follicular maturation, ovulation, and hormonal balance.

Arka Myo DCI Tablets offer a balanced combination of myo-inositol and D-chiro inositol in optimal ratios to support hormonal balance and reproductive health. By addressing underlying metabolic and hormonal imbalances, these tablets help improve fertility outcomes, regulate menstrual cycles, and alleviate symptoms associated with PCOS, such as irregular periods, acne, hirsutism, and infertility.